Literature DB >> 7719344

Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.

A O Wilkie1, S F Slaney, M Oldridge, M D Poole, G J Ashworth, A D Hockley, R D Hayward, D J David, L J Pulleyn, P Rutland.   

Abstract

Apert syndrome is a distinctive human malformation comprising craniosynostosis and severe syndactyly of the hands and feet. We have identified specific missense substitutions involving adjacent amino acids (Ser252Trp and Pro253Arg) in the linker between the second and third extracellular immunoglobulin (Ig) domains of fibroblast growth factor receptor 2 (FGFR2) in all 40 unrelated cases of Apert syndrome studied. Crouzon syndrome, characterized by craniosynostosis but normal limbs, was previously shown to result from allelic mutations of the third Ig domain of FGFR2. The contrasting effects of these mutations provide a genetic resource for dissecting the complex effects of signal transduction through FGFRs in cranial and limb morphogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719344     DOI: 10.1038/ng0295-165

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  179 in total

1.  Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes.

Authors:  K Yu; D M Ornitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Prominent basal emissary foramina in syndromic craniosynostosis: correlation with phenotypic and molecular diagnoses.

Authors:  C D Robson; J B Mulliken; R L Robertson; M R Proctor; D Steinberger; P D Barnes; A McFarren; U Müller; D Zurakowski
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

3.  TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor.

Authors:  J C Arevalo; B Conde; B L Hempstead; M V Chao; D Martin-Zanca; P Perez
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

4.  Why study human limb malformations?

Authors:  Andrew O M Wilkie
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

5.  Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome.

Authors:  Greg Holmes; Claudio Basilico
Journal:  Dev Biol       Date:  2012-06-01       Impact factor: 3.582

6.  Phenotypic expression of the fibroblast growth factor receptor 3 (FGFR3) mutation P250R in a large craniosynostosis family.

Authors:  A Golla; P Lichmer; S von Gernet; A Winterpacht; J Fairley; J Murken; S Schuffenhauer
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

7.  Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis.

Authors:  W Reardon; D Wilkes; P Rutland; L J Pulleyn; S Malcolm; J C Dean; R D Evans; B M Jones; R Hayward; C M Hall; N C Nevin; M Baraister; R M Winter
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

Review 8.  Fibroblast growth factor receptor mutations and craniosynostosis: three receptors, five syndromes.

Authors:  A O Wilkie
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

9.  A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes.

Authors:  M K Hajihosseini; S Wilson; L De Moerlooze; C Dickson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 10.  Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling.

Authors:  Anna Kutkowska-Kaźmierczak; Monika Gos; Ewa Obersztyn
Journal:  J Appl Genet       Date:  2018-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.